SS Body Armor I IncPBSOQ:PKN

0.3601
0.0049 / 1.34%
95.58k
50.04%
-1.2416
Close in USDToday's changeShares traded1 year changeBeta
Data delayed at least 15 minutes, as of Nov 21 2014 20:37 GMT.

About the company

203.09m-17.34m19941.30k
Revenue in USD (TTM)Net income in USDIncorporatedEmployees
IndustryAerospace & DefenseLocation
SS Body Armor I Inc
2102 SW 2nd Street
POMPANO BEACH33069
United States
USA
Phone+1 (954) 630-0900Fax+1 (302) 636-5454Websitehttp://www.pointblanksolutionsinc.com/
SS Body Armor I, Inc., formerly Point Blank Solutions, Inc., is a manufacturer and provider of bullet, fragmentation and stab resistant apparel and related ballistic accessories, which are used in the United States and internationally by military, law enforcement, security and corrections personnel, as well as government agencies. The Company's subsidiary Lifewear Technologies (LWT) manufactures and distributes sports medicine, health support and other products, including a variety of knee, ankle, elbow, wrist and back supports and braces that assist serious athletes, weekend sports enthusiasts and general consumers in their respective sports and everyday activities. All products are sold through contracts, a corporate sales force, sales agents and a network of distributors. In April 2010, the Company and its subsidiaries filed a voluntary petition for Chapter 11 reorganization.

Mergers & acquisitions

There are no recent mergers or acquisitions for SS Body Armor I Inc.
Data delayed at least 15 minutes, as of Nov 21 2014 20:37 GMT.

Peer analysis

Company Revenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings
(TTM)
Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excluding
extraordinary items (TTM)
EPS (including
extraordinary items) (TTM)
Revenue per
share (TTM)
Book value per
share (MRQ)
Asset turnover
(TTM)
Inventory turnover
(TTM)
Receivables turnover
(TTM)
Revenues per
employee (TTM)
Return on
average
assets
(TTM)
Return on
average
assets
(5 yr average)
Return on
investment
(TTM)
Return on
investment
(5 yr average)
Gross margin (TTM)Gross margin (5 yr average)Net profit margin (TTM)Net Profit margin (5 Yr Average)Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio (5 yr average)Revenue
(Year-over-year change%)
Revenue
(5 yr growth rate)
Net income
(Year-over-year change%)
Net income
(5 Yr growth rate)
Capital
expenditure
(5 Yr growth rate)
Dividend
(5 yr growth rate)
Repro-Med Systems, Inc.
9.96m900.41k14.85m6315.982.5212.901.490.02440.02440.26960.15471.593.027.49158,03814.3820.8216.3220.8261.3163.939.0412.174.54--0.000.0012.0420.39-3.0768-7.23527.59--
MetaStat Inc
0-8.33m15.10m6--17.88-----0.3595-0.35950.000.03080.00----0.00-652.8038-420.7161-1,095.006-420.7161-----------3.84470.2777-------112.8558--57.19--
Arch Therapeutics Inc
0-9.74m15.14m2---------0.1772-0.17720.00-0.13130.00----0.00-842.4049-----------------0.7531---------221.3309------
BSD Medical Corporation
5.33m-7.14m16.23m49--1.52--3.05-0.2036-0.20360.15240.26860.40081.238.35108,742-53.7274-50.4054-62.4939-50.405444.8436.72-134.0531-230.02995.45--0.0031--45.068.5513.44---2.3166--
Nephros, Inc.
1.63m-3.30m16.42m7------10.07-0.1593-0.15930.0747-0.01530.57623.5611.53233,000-116.4105-221.9084-1,007.645-221.908456.4142.42-202.0233-116.89260.4118-4.76911.32---3.70783.39-13.366------
ScripsAmerica, Inc.
4.70m-7.48m16.52m2------3.51-0.0893-0.08930.04820.00192.25--4.25---359.3892------84.99---159.628--0.9272-1.49011.04---85.794---479.793------
Hasco Medical Inc
88.11m1.37m17.72m7312.834.415.920.20110.00140.00160.08840.0042.825.0812.10--4.38--13.83--26.19--1.55--0.44692.810.8561--15.75--101.11------
Electromed, Inc.
16.84m-575.65k18.57m92--1.42122.521.10-0.0709-0.07092.081.620.99272.872.35183,046-3.3935-0.6328-3.9154-0.632868.7271.18-3.4183-0.534.222.780.0893--2.543.573.06--5.66--
SS Body Armor I Inc
203.09m-17.34m18.67m1.30k--0.6919--0.0919-0.3452-0.34524.120.52051.906.5218.44156,226-15.8863-26.2882-43.4593-26.28820.373717.68-8.3434-2.99870.8654--0.2428---48.5898-4.3854-187.0448--39.36--
Guided Therapeutics Inc
1.04m-11.03m19.18m30------18.49-0.151-0.1510.0142-0.04970.31170.93353.9234,566.67-267.4883---1,932.248--9.35---858.0521-207.77140.216-17.3011-----65.4252-2.1895-138.686------
Arrhythmia Research Technology, Inc.
24.42m554.31k19.25m9834.892.709.150.78820.20010.19858.732.581.576.847.81--3.57-5.57565.75-5.575618.7517.482.27-3.82730.71962.850.2502--3.38-1.0362-48.0428--10.10--
Bacterin International Holdings Inc
34.51m-11.37m19.42m128------0.5629-2.0264-2.02646.10-0.66691.101.147.73269,595-36.1796-86.4784-50.9583-86.478459.7466.97-32.9482-39.49711.29-1.75381.26--0.2835135.23-64.5505------
Positron Corp
1.64m-5.88m19.55m22------11.93-0.004-0.0040.0008-0.00110.64222.485.9074,454.55-230.5038------21.8610.00-358.9133-220.54420.0893-1.4162-----41.8065-5.174610.70--4.24--
Advanced Biomedical Technologies Inc
0-1.02m21.04m26---------0.0179-0.01790.00-0.06120.00----0.00-533.7889-----------------4.2846---------17.377------
Great Basin Scientific Inc
----21.13m70---------------0.0191------------------------0.4537------1,867.03---46.8394------
CNS Response, Inc.
158.00k-8.89m21.35m7------135.13-0.0481-0.04820.0012-0.01350.3072--17.6522,571.43-1,727.785------31.0859.41-5,624.051-2,289.575---53.1226----13.83-29.9126-273.3498------
Data as of Nov 23 2014. Currency figures normalised to SS Body Armor I Inc's reporting currency: US Dollar USD.

Institutional shareholders

There are no institutional shareholders for SS Body Armor I Inc.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.